<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ru">
	<id>https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=ELK1</id>
	<title>ELK1 - История изменений</title>
	<link rel="self" type="application/atom+xml" href="https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=ELK1"/>
	<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=ELK1&amp;action=history"/>
	<updated>2026-05-15T17:25:41Z</updated>
	<subtitle>История изменений этой страницы в вики</subtitle>
	<generator>MediaWiki 1.43.6</generator>
	<entry>
		<id>https://transhumanist.ru/index.php?title=ELK1&amp;diff=4664&amp;oldid=prev</id>
		<title>OdysseusBot: Новая страница: «ETS domain-containing protein Elk-1  ==Publications==  {{medline-entry |title=Tocotrienol-rich fraction prevents cellular aging by modulating cell proliferation s...»</title>
		<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=ELK1&amp;diff=4664&amp;oldid=prev"/>
		<updated>2021-04-29T19:28:47Z</updated>

		<summary type="html">&lt;p&gt;Новая страница: «ETS domain-containing protein Elk-1  ==Publications==  {{medline-entry |title=Tocotrienol-rich fraction prevents cellular aging by modulating cell proliferation s...»&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Новая страница&lt;/b&gt;&lt;/p&gt;&lt;div&gt;ETS domain-containing protein Elk-1&lt;br /&gt;
&lt;br /&gt;
==Publications==&lt;br /&gt;
&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=Tocotrienol-rich fraction prevents cellular aging by modulating cell proliferation signaling pathways.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/25945449&lt;br /&gt;
|abstract=Vitamin E has been suggested as nutritional intervention for the prevention of degenerative and age-related diseases. In this study, we aimed to elucidate the underlying mechanism of tocotrienol-rich fraction (TRF) in delaying cellular aging by targeting the proliferation signaling pathways in human diploid fibroblasts (HDFs). Tocotrienol-rich fraction was used to treat different stages of cellular aging of primary human diploid fibroblasts viz. young (passage 6), pre-senescent (passage 15) and senescent (passage 30). Several selected targets involved in the downstream of PI3K/AKT and RAF/MEK/ERK pathways were compared in total RNA and protein. Different transcriptional profiles were observed in young, pre-senescent and senescent HDFs, in which cellular aging increased AKT, [[FOXO3]], [[CDKN1A]] and RSK1 mRNA expression level, but decreased [[ELK1]], [[FOS]] and [[SIRT1]] mRNA expression level. With tocotrienol-rich fraction treatment, gene expression of AKT, [[FOXO3]], ERK and RSK1 mRNA was decreased in senescent cells, but not in young cells. The three down-regulated mRNA in cellular aging, [[ELK1]], [[FOS]] and [[SIRT1]], were increased with tocotrienol-rich fraction treatment. Expression of [[FOXO3]] and P21Cip1 proteins showed up-regulation in senescent cells but tocotrienol-rich fraction only decreased P21Cip1 protein expression in senescent cells. Tocotrienol-rich fraction exerts gene modulating properties that might be responsible in promoting cell cycle progression during cellular aging.&lt;br /&gt;
|mesh-terms=* Antioxidants&lt;br /&gt;
* Cell Proliferation&lt;br /&gt;
* Cells, Cultured&lt;br /&gt;
* Cellular Senescence&lt;br /&gt;
* Diploidy&lt;br /&gt;
* Fibroblasts&lt;br /&gt;
* Humans&lt;br /&gt;
* Tocotrienols&lt;br /&gt;
* Vitamin E&lt;br /&gt;
|keywords=* Cellular aging&lt;br /&gt;
* Gene expression&lt;br /&gt;
* Human diploid fibroblasts&lt;br /&gt;
* Tocotrienol-rich fraction&lt;br /&gt;
* Vitamin E&lt;br /&gt;
|full-text-url=https://sci-hub.do/10.7417/CT.2015.1825&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>OdysseusBot</name></author>
	</entry>
</feed>